0
ARTICLE |

Localization and Quantitation of Blood-Retinal Barrier Breakdown in Experimental Proliferative Vitreoretinopathy FREE

Noburo Ando, MD; Harsha A. Sen, MD; Bruce A. Berkowitz, PhD; Charles A. Wilson, MD; Eugene de Juan, Jr, MD
Arch Ophthalmol. 1994;112(1):117-122. doi:10.1001/archopht.1994.01090130127029
Text Size: A A A
Published online

Objective:  To determine the contribution of the break-down of the blood-retinal barrier (BRB) as measured with magnetic resonance imaging in the development of retinal detachment in an experimental model of proliferative vitreoretinopathy.

Methods:  Contrast-enhanced magnetic resonance imaging was used to evaluate BRB breakdown in an intravitreal cell-injection model of proliferative vitreoretinopathy. Intravitreal injection of 2.5×105 homologous dermal fibroblasts produced specific disruption of the inner, or vascular, BRB.

Results:  Breakdown of the BRB was greatest in the first 3 days after injection, confirming previous work using fluorescein-based methods. Injection of 1 mg of intravitreal triamcinolone acetonide at the time of cell injection significantly reduced both BRB breakdown and the incidence of eventual traction retinal detachment. Eyes that did develop detachment had significantly greater leakage prior to its development than those that did not, regardless of steroid treatment.

Conclusions:  Quantitation and definitive localization of BRB leakage with magnetic resonance imaging provides a better understanding of the relationship between BRB compromise and the development of retinal detachment in this frequently used model.

REFERENCES

Kampik A, Kenyon KR, Michels RG, et al.  Epiretinal and vitreous membranes: a comparative study of 56 cases . Arch Ophthalmol . 1981;;99:1445-1454.
Laqua H, Machemer R.  Clinical-pathologic correlation in massive periretinal proliferation . Am J Ophthalmol . 1975;;80:913-929.
Machemer R.  Massive periretinal proliferation: a logical approach to therapy . Trans Am Ophthalmol Soc . 1977;;75:556-586.
Sternberg P, Machemer R.  Result of conventional vitreous surgery for vitreoretinopathy . Am J Ophthalmol . 1985;;100:141-146.
Sunalp M, Wiedemann D, Sorgente NJ, Ryan T.  Effects of cytotoxic drugs on proliferative vetreoretinopathy in the rabbit cell injection model . Curr Eye Res . 1984;;34:619-623.
Sen HA, Robertson TJ, Conway BP, Campochiaro PA.  The role of breakdown of the blood-retinal barrier in cell-injection models of proliferative vitreoretinopathy . Arch Ophthalmol . 1988;;106:1291-1294.
Campochiaro PA, Sen HA, Robertson TJ, Conway BP.  The role of breakdown of the blood-retinal barrier in proliferative vitreoretinopathy . In: Proliferative Vitreoretinopathy . Heidelberg, Germany: Kadon Verlag; 1989;;45-49.
The Retina Society Terminology Committee.  Classification of retinal detachment with proliferative vitreoretinopathy . Ophthalmology . 1983;;90:121-125.
Campochiaro PA, Bryan JA III, Conway BP, Jaccoma EH.  Intravitreal chemotactic and mitogenic activity: implication of blood-retinal barrier breakdown . Arch Ophthalmol . 1986;;104:1685-1687.
Algvere PV, Hallnas K, Dafgard E, Hoog A.  Panretinal photocoagulation aggravates experimental proliferative vitreoretinopathy . Graefes Arch Clin Exp Ophthalmol . 1990;;228:461-466.
Campochiaro PA, Gaskin HC, Vinores SA.  Retinal cryopexy stimulates traction retinal detachment formation in the presence of an ocular wound . Arch Ophthalmol . 1987;;105:1567-1570.
Campochiaro PA, Jerdan JA, Glaser BM.  Serum contains chemoattractants for human retinal pigment epithelial cells . Arch Ophthalmol . 1984;;102:1830-1833.
Campochiaro PA, Glaser BM.  Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells . Arch Ophthalmol . 1985;;103:576-579.
Gauss-Muller V, Kleinman H, Martin GR, et al.  Role of attachment and attractants in fibroblast chemotaxis . J Lab Clin Med . 1980;;96:1071-1080.
de Juan E Jr, Dickson J, Hjelmeland L.  Serum is chemotactic for retinal-derived glial cells . Arch Ophthalmol . 1988;;106:986-990.
Cunha-Vaz JG.  The blood-ocular barriers . Surv Ophthalmol . 1979;;23:279-296.
Bito LZ, DeRousseau CJ.  Transport functions of the blood-retinal barrier system and the microenvironment of the retina . In: Cunha-Vaz JG, ed. The Blood-Retinal Barriers . New York, NY: Plenum Press; 1980;:133-163.
Conway BP.  Technical variables in vitreous fluorophotometry . Graefes Arch Clin Exp Ophthalmol . 1985;;222:194-201.
Plehwe WE, McRobbie DW, Lerski RA, Kohner EM.  Quantitative MRI in assessment of the blood-retinal barrier . Invest Ophthalmol Vis Sci . 1988;;29:663-670.
Berkowitz BA, Sato Y, Wilson DA, de Juan E Jr.  Blood retinal barrier breakdown investigated by real-time MRI following Gd-DTPA injection . Invest Ophthalmol Vis Sci . 1991;;32:2854-2860.
Sato Y, Berkowitz BA, Wilson CA, de Juan E Jr.  Blood-retinal barrier break-down caused by diode and argon laser endophotocoagulation: a comparative MRI study . Arch Ophthalmol . 1992;;110:277-281.
Berkowitz BA, Tofts P, Sen HA, Ando N, de Juan E Jr.  Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI . Invest Ophthalmol Vis Sci . 1992;;33:3500-3506.
Sen HA, Berkowitz BA, Ando N, de Juan E Jr.  In vivo imaging of breakdown of the inner and outer blood-retinal barriers . Invest Ophthalmol Vis Sci . 1992;;33:3507-3512.
Sugita G, Tano Y, Machemer R, et al.  Intravitreal autotransplantation of fibroblasts . Am J Ophthalmol . 1980;;89:121-130.
Chandler DB, Hida T, Sheta S, et al.  Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment . Graefes Arch Clin Exp Ophthalmol . 1987;;225:259-265.
Tano Y, Chandler D, Machemer R.  Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide . Am J Ophthalmol . 1980;;90:810-816.
Wyatt JD, Scott RAW, Richardson ME.  The effect of prolonged ketamine-xylazine intravenous infusion on arterial blood pH, blood gases, mean arterial blood pressure, heart and respiratory rates, rectal temperature and reflexes in the rabbit . Lab Anim Sci . 1989;;39:411-416.
de Juan E Jr, Humayun M, Wilson D, Hatchell D.  Histopathology of experimental preretinal neovascularization . Invest Ophthalmol Vis Sci . 1989;;30:1495-1503.
de Juan E Jr, Wilson D, Hatchell D.  Breakdown of the blood-retinal barrier in a model of retinal neovascularization . Invest Ophthalmol Vis Sci . 1987;;28:1108-1115.
Hatchell DL, McAdoo T, Sheta S, et al.  Quantification of cellular proliferation in experimental proliferative vitreoretinopathy . Arch Ophthalmol . 1988;;106:669-672.
Fastenberg DM, Diddie KR, Dorey K, Ryan SJ.  The role of cellular proliferation in an experimental model of massive periretinal proliferation . Am J Ophthalmol . 1982;;93:565-572.
Tano Y, Sugita G, Abrams G, Machemer R.  Inhibition of intraocular proliferations with intravitreal corticosteroids . Am J Ophthalmol . 1980;;89:131-136.
McCuen BW, Bessler M, Tano Y, et al.  The lack of toxicity of intravitreally administered triamcinolone acetonide . Am J Ophthalmol . 1981;;91:785-788.
Ruhmann AG, Berliner DL.  Effect of steroids on growth of mouse fibroblasts in vitro . Endocrinology . 1965;;76:916-920.
Dannenberg AM.  The anti-inflammatory effects of glucocorticosteroids: a brief review of the literature . Inflammation . 1979;;3:329-343.
Blankenship GW.  Evaluation of a single intravitreal injection of dexamethasone phosphate in vitrectomy surgery for diabetic retinopathy complications . Graefes Arch Clin Exp Ophthalmol . 1991;;229:62-65.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Kampik A, Kenyon KR, Michels RG, et al.  Epiretinal and vitreous membranes: a comparative study of 56 cases . Arch Ophthalmol . 1981;;99:1445-1454.
Laqua H, Machemer R.  Clinical-pathologic correlation in massive periretinal proliferation . Am J Ophthalmol . 1975;;80:913-929.
Machemer R.  Massive periretinal proliferation: a logical approach to therapy . Trans Am Ophthalmol Soc . 1977;;75:556-586.
Sternberg P, Machemer R.  Result of conventional vitreous surgery for vitreoretinopathy . Am J Ophthalmol . 1985;;100:141-146.
Sunalp M, Wiedemann D, Sorgente NJ, Ryan T.  Effects of cytotoxic drugs on proliferative vetreoretinopathy in the rabbit cell injection model . Curr Eye Res . 1984;;34:619-623.
Sen HA, Robertson TJ, Conway BP, Campochiaro PA.  The role of breakdown of the blood-retinal barrier in cell-injection models of proliferative vitreoretinopathy . Arch Ophthalmol . 1988;;106:1291-1294.
Campochiaro PA, Sen HA, Robertson TJ, Conway BP.  The role of breakdown of the blood-retinal barrier in proliferative vitreoretinopathy . In: Proliferative Vitreoretinopathy . Heidelberg, Germany: Kadon Verlag; 1989;;45-49.
The Retina Society Terminology Committee.  Classification of retinal detachment with proliferative vitreoretinopathy . Ophthalmology . 1983;;90:121-125.
Campochiaro PA, Bryan JA III, Conway BP, Jaccoma EH.  Intravitreal chemotactic and mitogenic activity: implication of blood-retinal barrier breakdown . Arch Ophthalmol . 1986;;104:1685-1687.
Algvere PV, Hallnas K, Dafgard E, Hoog A.  Panretinal photocoagulation aggravates experimental proliferative vitreoretinopathy . Graefes Arch Clin Exp Ophthalmol . 1990;;228:461-466.
Campochiaro PA, Gaskin HC, Vinores SA.  Retinal cryopexy stimulates traction retinal detachment formation in the presence of an ocular wound . Arch Ophthalmol . 1987;;105:1567-1570.
Campochiaro PA, Jerdan JA, Glaser BM.  Serum contains chemoattractants for human retinal pigment epithelial cells . Arch Ophthalmol . 1984;;102:1830-1833.
Campochiaro PA, Glaser BM.  Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells . Arch Ophthalmol . 1985;;103:576-579.
Gauss-Muller V, Kleinman H, Martin GR, et al.  Role of attachment and attractants in fibroblast chemotaxis . J Lab Clin Med . 1980;;96:1071-1080.
de Juan E Jr, Dickson J, Hjelmeland L.  Serum is chemotactic for retinal-derived glial cells . Arch Ophthalmol . 1988;;106:986-990.
Cunha-Vaz JG.  The blood-ocular barriers . Surv Ophthalmol . 1979;;23:279-296.
Bito LZ, DeRousseau CJ.  Transport functions of the blood-retinal barrier system and the microenvironment of the retina . In: Cunha-Vaz JG, ed. The Blood-Retinal Barriers . New York, NY: Plenum Press; 1980;:133-163.
Conway BP.  Technical variables in vitreous fluorophotometry . Graefes Arch Clin Exp Ophthalmol . 1985;;222:194-201.
Plehwe WE, McRobbie DW, Lerski RA, Kohner EM.  Quantitative MRI in assessment of the blood-retinal barrier . Invest Ophthalmol Vis Sci . 1988;;29:663-670.
Berkowitz BA, Sato Y, Wilson DA, de Juan E Jr.  Blood retinal barrier breakdown investigated by real-time MRI following Gd-DTPA injection . Invest Ophthalmol Vis Sci . 1991;;32:2854-2860.
Sato Y, Berkowitz BA, Wilson CA, de Juan E Jr.  Blood-retinal barrier break-down caused by diode and argon laser endophotocoagulation: a comparative MRI study . Arch Ophthalmol . 1992;;110:277-281.
Berkowitz BA, Tofts P, Sen HA, Ando N, de Juan E Jr.  Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI . Invest Ophthalmol Vis Sci . 1992;;33:3500-3506.
Sen HA, Berkowitz BA, Ando N, de Juan E Jr.  In vivo imaging of breakdown of the inner and outer blood-retinal barriers . Invest Ophthalmol Vis Sci . 1992;;33:3507-3512.
Sugita G, Tano Y, Machemer R, et al.  Intravitreal autotransplantation of fibroblasts . Am J Ophthalmol . 1980;;89:121-130.
Chandler DB, Hida T, Sheta S, et al.  Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment . Graefes Arch Clin Exp Ophthalmol . 1987;;225:259-265.
Tano Y, Chandler D, Machemer R.  Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide . Am J Ophthalmol . 1980;;90:810-816.
Wyatt JD, Scott RAW, Richardson ME.  The effect of prolonged ketamine-xylazine intravenous infusion on arterial blood pH, blood gases, mean arterial blood pressure, heart and respiratory rates, rectal temperature and reflexes in the rabbit . Lab Anim Sci . 1989;;39:411-416.
de Juan E Jr, Humayun M, Wilson D, Hatchell D.  Histopathology of experimental preretinal neovascularization . Invest Ophthalmol Vis Sci . 1989;;30:1495-1503.
de Juan E Jr, Wilson D, Hatchell D.  Breakdown of the blood-retinal barrier in a model of retinal neovascularization . Invest Ophthalmol Vis Sci . 1987;;28:1108-1115.
Hatchell DL, McAdoo T, Sheta S, et al.  Quantification of cellular proliferation in experimental proliferative vitreoretinopathy . Arch Ophthalmol . 1988;;106:669-672.
Fastenberg DM, Diddie KR, Dorey K, Ryan SJ.  The role of cellular proliferation in an experimental model of massive periretinal proliferation . Am J Ophthalmol . 1982;;93:565-572.
Tano Y, Sugita G, Abrams G, Machemer R.  Inhibition of intraocular proliferations with intravitreal corticosteroids . Am J Ophthalmol . 1980;;89:131-136.
McCuen BW, Bessler M, Tano Y, et al.  The lack of toxicity of intravitreally administered triamcinolone acetonide . Am J Ophthalmol . 1981;;91:785-788.
Ruhmann AG, Berliner DL.  Effect of steroids on growth of mouse fibroblasts in vitro . Endocrinology . 1965;;76:916-920.
Dannenberg AM.  The anti-inflammatory effects of glucocorticosteroids: a brief review of the literature . Inflammation . 1979;;3:329-343.
Blankenship GW.  Evaluation of a single intravitreal injection of dexamethasone phosphate in vitrectomy surgery for diabetic retinopathy complications . Graefes Arch Clin Exp Ophthalmol . 1991;;229:62-65.

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.